Skip to search boxSkip to navigationSkip to main content

BIN1 is a novel MYC-interacting protein with features of a tumour suppressor

  • ,
  • Katherine J. Elliott
    ,
  • Robert Wechsler-Reya
    ,
  • George C. Prendergast(corresponding author)
*Corresponding author for this work
  • Wistar Institute
Scholary Output:
Contribution to journal
Article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

BIN1 is a novel protein that interacts with the functionally critical Myc box regions at the N terminus of the MYC oncoprotein. BIN1 is structurally related to amphiphysin, a breast cancer-associated autoimmune antigen, and RVS167, a negative regulator of the yeast cell cycle, suggesting roles in malignancy and cell cycle control. Consistent with this likelihood, BIN1 inhibited malignant cell transformation by MYC. Although BIN1 is expressed in many normal cells, its levels were greatly reduced or undetectable in 14/27 carcinoma cell lines and 3/6 primary breast tumours. Deficits were functionally significant because ectopic expression of BIN1 inhibited the growth of tumour cells lacking endogenous message. We conclude that BIN1 is an MYC-interacting protein with features of a tumour suppressor.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 69-77 (9 pages)

Journal (Volume, Issue Number)

Nature Genetics (Volume 14, Issue 1)

Publication milestones

  • Published - 09/1996

Publication status

Published - 09/1996

ISSN

1061-4036

Publication IDs

  • Scopus: 0029741917
  • PubMed: 8782822

Publication metrics

Metrics

Scopus
citations
SciVal
citations
295
SciVal
FWCI
6.16
SciVal
Author count
4
SciVal
Paper percentile
99
SciVal
Top percentile
1
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Mentions
3
Captures
157
Citation count
350

Funding Details

FunderFunding number
NCI
P30CA010815